Impact of Time to Treatment on Myocardial Reperfusion and Infarct Size With Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the EMERALD Trial) - 16/08/11
, John Webb, MD d, David A. Cox, MD b, Mansoor Qureshi, MD e, Anna Kalynych, MD g, Mark Turco, MD h, Heinz P. Schultheiss, MD i, Daniel Dulas, MD f, Barry Rutherford, MD j, David Antoniucci, MD k, Tom Stuckey, MD a, Mitch Krucoff, MD c, Raymond Gibbons, MD l, Alexandra Lansky, MD m, Yingbo Na, MD m, Roxana Mehran, MD m, Gregg W. Stone, MD mEMERALD Investigators
Corresponding author: Tel.: 336-547-1756; fax: 336-851-8427.Résumé |
The impact of time to treatment on outcomes after primary percutaneous coronary intervention (PCI) is controversial, and there are few data about time to treatment and infarct size. The EMERALD trial randomly assigned 501 high-risk patients with ST-elevation myocardial infarction undergoing primary PCI to stenting with or without GuardWire (Medtronic, Santa Rosa, California) distal protection. Infarct size using sestamibi imaging at 5 to 14 days and clinical outcomes were examined by time to treatment. There were no differences in outcomes between distal protection and control patients. Shorter time to reperfusion (<2 vs 2 to 3 vs >3 to 4 vs >4 hours) was associated with smaller infarct size (2% vs 9% vs 12% vs 11%, p = 0.026), trends for better myocardial blush (p = 0.08), and lower 6-month mortality rates (0% vs 0% vs 2.4% vs 5.3%, p = 0.06). Incremental delays in reperfusion after 2 hours had little impact on infarct size. Shorter time to reperfusion impacted on infarct size in patients with anterior infarction (0% vs 17% vs 20.5% vs 30.5%, p = 0.026), but not nonanterior infarction (3% vs 7% vs 7.5% vs 10%, p = 0.23, p = 0.022 for interaction). In conclusion, very early reperfusion with primary PCI is associated with smaller infarct size and has a much greater impact in anterior versus nonanterior infarction. Incremental delays in reperfusion after 2 hours have less effect on infarct size. These data have implications regarding the triage of patients for primary PCI.
Le texte complet de cet article est disponible en PDF.Plan
| This study was supported by Medtronic Inc, Minneapolis, Minnesota. |
Vol 99 - N° 12
P. 1680-1686 - juin 2007 Retour au numéro
Article précédent
- Impact of Admission Hyperglycemia and Diabetes Mellitus on Short- and Long-Term Mortality After Acute Myocardial Infarction in the Coronary Intervention Era
- Masaharu Ishihara, Eisuke Kagawa, Ichiro Inoue, Takuji Kawagoe, Yuji Shimatani, Satoshi Kurisu, Yasuharu Nakama, Tatsuya Maruhashi, Keisuke Ookawa, Kazuoki Dai, Yasuyuki Aokage
- Association of Prerandomization Anticoagulant Switching With Bleeding in the Setting of Percutaneous Coronary Intervention (A REPLACE-2 Analysis)
- C. Michael Gibson, Yuli Ten, Sabina A. Murphy, Lauren N. Ciaglo, Matthew C. Southard, A. Michael Lincoff, Ron Waksman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?